Goldman Sachs on Max Healthcare Institute: Buy| Target Rs 1325| LTP Rs 1097| Upside 20%
Goldman Sachs has a Buy rating on Max Healthcare Institute with a target of Rs 1,325, suggesting a 20% upside from the current market price of Rs 1,097.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)